CD274 and neoplasm: Our study demonstrates that AI-powered quantification of PD-L1 expression on TCs identified more PD-L1–positive samples compared with manual scoring across several tumor types explored in this study, while demonstrating consistent associations with response and survival across multiple clinical trial datasets.